Individualized dosimetry-based activity reduction of 90Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy
Title:
Individualized dosimetry-based activity reduction of 90Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapy
Author:
Binnebeek, Sofie Van Baete, Kristof Vanbilloen, Bert Terwinghe, Christelle Koole, Michel Mottaghy, Felix M. Clement, Paul M. Mortelmans, Luc Haustermans, Karin Cutsem, Eric Van Verbruggen, Alfons Bogaerts, Kris Verslype, Chris Deroose, Christophe M.
Appeared in:
European journal of nuclear medicine and molecular imaging